Medicare Enrolled
Dr. Akin Ogundipe, M.D.
Optician · Marietta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ogundipe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ogundipe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ogundipe
Dr. Akin Ogundipe is an optician specialist in Marietta, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ogundipe performed 5,107 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ogundipe received a total of $4,875 from 40 pharmaceutical and/or device companies across 226 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ogundipe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 10% volume in GA
$4,875 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,107
Medicare services
Top 10% in GA for optician
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,223 | $6 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
905 | $63 | $160 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
369 | $278 | $694 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
328 | $4 | $23 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
212 | $94 | $224 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
209 | $56 | $147 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $92 | $216 |
| Dialysis services, partial month (age 20+) Dialysis treatment provided for a partial month of service for patients aged 20 years or older. |
107 | $8 | $25 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
93 | $57 | $368 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
92 | $134 | $450 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
79 | $224 | $600 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
79 | $11 | $53 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
75 | $2 | $25 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
71 | $231 | $592 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $105 | $298 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
36 | $40 | $85 |
| Annual depression screening | 17 | $18 | $20 |
| Monthly dialysis physician visit A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment. |
16 | $158 | $488 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $134 | $332 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,875
Total received (2018-2024)
Avg $696/year across 7 years
Top 23% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
226
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,152
2023
$546
2022
$540
2021
$71
2020
$991
2019
$861
2018
$712
Payments by company (2024)
Amgen Inc.
$212
Novartis Pharmaceuticals Corporation
$189
Otsuka America Pharmaceutical, Inc.
$148
Fresenius USA Marketing, Inc.
$79
Aurinia Pharma U.S., Inc.
$79
Daiichi Sankyo Inc.
$75
AstraZeneca Pharmaceuticals LP
$75
Travere Therapeutics, Inc.
$72
Lilly USA, LLC
$37
Alnylam Pharmaceuticals Inc.
$36
Janssen Pharmaceuticals, Inc
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
OPKO Pharmaceuticals, LLC
$22
CALLIDITAS THERAPEUTICS US INC.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
PFIZER INC.
$15
Vifor Pharma, Inc.
$14
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka Pharmaceutical Development & Commercialization, Inc.
$718
Otsuka America Pharmaceutical, Inc.
$547
Amgen Inc.
$360
Fresenius USA Marketing, Inc.
$357
Horizon Therapeutics plc
$346
AstraZeneca Pharmaceuticals LP
$266
Relypsa, Inc.
$248
Travere Therapeutics, Inc.
$200
Novartis Pharmaceuticals Corporation
$189
Mallinckrodt LLC
$138
AKEBIA THERAPEUTICS INC
$132
Aurinia Pharma U.S., Inc.
$125
PFIZER INC.
$121
OPKO Pharmaceuticals, LLC
$106
Bayer Healthcare Pharmaceuticals Inc.
$106
Mallinckrodt Enterprises LLC
$97
Daiichi Sankyo Inc.
$75
GlaxoSmithKline, LLC.
$70
Alexion Pharmaceuticals, Inc.
$59
Janssen Pharmaceuticals, Inc
$58
Lilly USA, LLC
$56
Vifor Pharma, Inc.
$53
Alnylam Pharmaceuticals Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$47
AMAG Pharmaceuticals, Inc.
$38
Horizon Pharma plc
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
Mallinckrodt Hospital Products Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
Lundbeck LLC
$22
CALLIDITAS THERAPEUTICS US INC.
$22
Kyowa Kirin, Inc.
$20
Exeltis, USA Inc.
$20
CHF Solutions, Inc
$20
Shire North American Group Inc
$18
Genentech USA, Inc.
$17
GENZYME CORPORATION
$16
Calliditas Therapeutics US Inc.
$14
Ultragenyx Pharmaceutical Inc.
$11
Top 3 companies account for 33.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aimovig · Aquadex · Aranesp · BENLYSTA · CHANTIX · CRYSVITA · Empaveli · FABRY-DISEASE · FARXIGA · FERAHEME · Fabhalta · GATTEX · IBRANCE · INJECTAFER · INVOKANA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NORTHERA · Not Product Related · OXLUMO · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rituxan · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · Thiola · ULTOMIRIS · Uloric · Velphoro · Veltassa · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
532
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ogundipe is a mixed practice specialist, with above-average Medicare volume (top 10% in GA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ogundipe experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Ogundipe performed 2,223 epoetin alfa injection (procrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ogundipe receive payments from pharmaceutical companies?
Yes. Dr. Ogundipe received a total of $4,875 from 40 companies across 226 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ogundipe's costs compare to other opticians in Marietta?
Dr. Ogundipe's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ogundipe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Marietta
Browse opticians in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
Otsuka Pharmaceutical Development & Commercialization, Inc. Payments to Doctors
See all physicians who received payments from Otsuka Pharmaceutical Development & Commercialization, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology